The Claim
In adults with type 2 diabetes, elevated levels of suPAR are associated with the highest relative risk of all-cause mortality among three inflammatory biomarkers, with a 70% mortality rate in the top tertile and 19% in the bottom tertile.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among adults with type 2 diabetes, those with the highest levels of suPAR have a 70% chance of dying from any cause during the study period, while those with the lowest levels have a 19% chance.
See the scientific wording
In adults with type 2 diabetes, elevated levels of suPAR are associated with the highest relative risk of all-cause mortality among the three inflammatory biomarkers studied, with a 70% mortality rate in the top tertile compared to 19% in the bottom tertile.
High levels of suPAR activate immune cells, which damage blood vessel walls and cause organs to fail over time, leading to death.
What the research says
1 studyIn people with type 2 diabetes, those with the highest levels of a blood marker called suPAR were much more likely to die over 13 years—70% compared to just 19% for those with the lowest levels. The study directly found this.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.